Versant Ventures’ Century Therapeutics has secured $250m to develop allogeneic immune cell therapies for the treatment of cancer patients. The...
Read More...
The post Century Therapeutics secures $250m to develop cancer drugs appeared first on Pharmaceutical Technology.
Original Article: Century Therapeutics secures $250m to develop cancer drugs